Vireo Growth INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

OTC.Pink
Vireo Growth Inc. reports a significant 170% revenue increase in 2025 driven by strategic mergers, despite incurring net losses, as it navigates a complex and evolving cannabis market.
OTC.Pink
Vireo Growth Inc. files its 10-K report, detailing its financial performance for the year ended December 31, 2024, and outlining its strategic objectives for the coming year.
OTC.Pink
Goodness Growth Holdings files an amendment to its annual report on Form 10-K, including details on executive compensation and amendments to employment agreements.
OTC.Pink
Goodness Growth Holdings has disclosed a non-statutory stock option agreement for Kyle Kingsley and a non-plan stock option agreement for Joshua Rosen, alongside its annual 10-K filing, detailing the terms of executive compensation.